X4 Pharmaceuticals (XFOR) EBIT Margin Growth (1y) (2025)

X4 Pharmaceuticals (XFOR) EBIT Margin Growth (1y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -
4 BeOne Medicines 471.58 Bn 466.79 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn -170.00
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.80 Bn 50.61 Bn 1.41 Bn 1,049.00
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn 1,997.00
10 X4 Pharmaceuticals 167.69 Mn -49.36 Mn 2.20 Mn 156,773.00

Historic Data

Download Data
DateValue
Dec 31, 2025 156,773.00
Sep 30, 2025 460,213.00
Jun 30, 2025 -1.40 Mn